Overall survival of patients submitted to autologous BM transplantation. Probability of survival for lymphoma/myeloma (LY/MM) and acute leukemia (AL) patients undergoing reinfusion of autologous primed BM to support high-dose chemotherapy. N.S. indicates not significant.